Abstract:A frameshift (fs) mutation in the natriuretic peptide precursor A (NPPA) gene, encoding a mutant atrial natriuretic peptide (Mut-ANP), has been linked with familial atrial fibrillation (AF) but the underlying mechanisms by which the mutation causes AF remain unclear. We engineered 2 transgenic (TG) mouse lines expressing the wild-type (WT)-NPPA gene (H-WT-NPPA) and the human fs-Mut-NPPA gene (H-fsMut-NPPA) to test the hypothesis that mice overexpressing the human NPPA mutation are more susceptible to AF and elucidate the underlying electrophysiologic and molecular mechanisms. Transthoracic echocardiography and surface electrocardiography (ECG) were performed in H-fsMut-NPPA, H-WT-NPPA, and Non-TG mice. Invasive electrophysiology, immunohistochemistry, Western blotting and patch clamping of membrane potentials were performed. To examine the role of the Mut-ANP in ion channel remodeling, we measured plasma cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP) levels and protein kinase A (PKA) activity in the 3 groups of mice. In H-fsMut-NPPA mice mean arterial pressure (MAP) was reduced when compared to H-WT-NPPA and Non-TG mice. Furthermore, injection of synthetic fs-Mut-ANP lowered the MAP in H-WT-NPPA and Non-TG mice while synthetic WT-ANP had no effect on MAP in the 3 groups of mice. ECG characterization revealed significantly prolonged QRS duration in H-fsMut-NPPA mice when compared to the other two groups. Trans-Esophageal (TE) atrial pacing of H-fsMut-NPPA mice showed increased AF burden and AF episodes when compared with H-WT-NPPA or Non-TG mice. The cardiac Na+ (NaV1.5) and Ca2+ (CaV1.2/CaV1.3) channel expression and currents (INa, ICaL) and action potential durations (APD90/APD50/APD20) were significantly reduced in H-fsMut-NPPA mice while the rectifier K+ channel current (IKs) was markedly increased when compared to the other 2 groups of mice. In addition, plasma cGMP levels were only increased in H-fsMut-NPPA mice with a corresponding reduction in plasma cAMP levels and PKA activity. In summary, we showed that mice overexpressing an AF-linked NPPA mutation are more prone to develop AF and this risk is mediated in part by remodeling of the cardiac Na+, Ca2+ and K+ channels creating an electrophysiologic substrate for reentrant AF.

Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

Lamin A Mutation Impairs Interaction with Nucleoporin NUP155 and Disrupts Nucleocytoplasmic Transport in Atrial Fibrillation

A Kir2.1 Gain-of-function Mutation Underlies Familial Atrial Fibrillation.

Nkx2-6 Mutation Predisposes To Familial Atrial Fibrillation

A Novel NKX2.5 Loss-of-function Mutation Responsible for Familial Atrial Fibrillation.

Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation

Mutational Spectrum of the NKX2-5 Gene in Patients with Lone Atrial Fibrillation

KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation As Well As Ventricular Arrhythmias and Cardiomyopathy

Connexin40 Nonsense Mutation in Familial Atrial Fibrillation.

PRRX1 Loss‐of‐Function Mutations Underlying Familial Atrial Fibrillation

Genome-Wide Linkage Scan Identifies a Novel Genetic Locus on Chromosome 5p13 for Neonatal Atrial Fibrillation Associated with Sudden Death and Variable Cardiomyopathy

A Novel Pitx2c Loss-Of-Function Mutation Underlies Lone Atrial Fibrillation

[Identification and Functional Analysis of a KCNA5 Mutation Responsible for Idiopathic Atrial Fibrillation].

SNX17 (sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (potassium Voltage-Gated Channel Subfamily A Member 5) Channel

Connexin45 (<i>GJC1</i>) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease

A SHOX2 Loss-of-function Mutation Underlying Familial Atrial Fibrillation

A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation

Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease